Immunological detection of severe acute respiratory syndrome coronavirus by monoclonal antibodies - PubMed (original) (raw)
Masahiro Sakaguchi, Tomohiro Kaji, Kiyoko Akagawa, Tadayoshi Taniyama, Masataka Kasai, Yasuko Tsunetsugu-Yokota, Masamichi Oshima, Kiichi Yamamoto, Naomi Takasuka, Shu-ichi Hashimoto, Manabu Ato, Hideki Fujii, Yoshimasa Takahashi, Shigeru Morikawa, Koji Ishii, Tetsutaro Sata, Hirotaka Takagi, Shigeyuki Itamura, Takato Odagiri, Tatsuo Miyamura, Ichiro Kurane, Masato Tashiro, Takeshi Kurata, Hiroshi Yoshikura, Toshitada Takemori
Affiliations
- PMID: 15858286
Immunological detection of severe acute respiratory syndrome coronavirus by monoclonal antibodies
Kazuo Ohnishi et al. Jpn J Infect Dis. 2005 Apr.
Abstract
In order to establish immunological detection methods for severe acute respiratory syndrome coronavirus (SARS-CoV), we established monoclonal antibodies directed against structural components of the virus. B cell hybridomas were generated from mice that were hyper-immunized with inactivated SARS-CoV virion. By screening 2,880 generated hybridomas, we established three hybridoma clones that secreted antibodies specific for nucleocapsid protein (N) and 27 clones that secreted antibodies specific for spike protein (S). Among these, four S-protein specific antibodies had in vitro neutralization activity against SARS-CoV infection. These monoclonal antibodies enabled the immunological detection of SARS-CoV by immunofluorescence staining, Western blot or immunohistology. Furthermore, a combination of monoclonal antibodies with different specificities allowed the establishment of a highly sensitive antigen-capture sandwich ELISA system. These monoclonal antibodies would be a useful tool for rapid and specific diagnosis of SARS and also for possible antibody-based treatment of the disease.
Similar articles
- Establishment and characterization of monoclonal antibodies against SARS coronavirus.
Ohnishi K. Ohnishi K. Methods Mol Biol. 2008;454:191-203. doi: 10.1007/978-1-59745-181-9_15. Methods Mol Biol. 2008. PMID: 19057876 Free PMC article. - [Development and application of triple antibodies-based sandwich ELISA for detecting nucleocapsid protein of SARS-associated coronavirus].
Qiu LW, Tang HW, Wang YD, Liao JE, Hao W, Wen K, He XM, Che XY. Qiu LW, et al. Zhonghua Liu Xing Bing Xue Za Zhi. 2005 Apr;26(4):277-81. Zhonghua Liu Xing Bing Xue Za Zhi. 2005. PMID: 15941537 Chinese. - Epitope mapping and biological function analysis of antibodies produced by immunization of mice with an inactivated Chinese isolate of severe acute respiratory syndrome-associated coronavirus (SARS-CoV).
Chou TH, Wang S, Sakhatskyy PV, Mboudjeka I, Lawrence JM, Huang S, Coley S, Yang B, Li J, Zhu Q, Lu S. Chou TH, et al. Virology. 2005 Mar 30;334(1):134-43. doi: 10.1016/j.virol.2005.01.035. Virology. 2005. PMID: 15749129 Free PMC article. - Characterization and epitope mapping of monoclonal antibodies to the nucleocapsid protein of severe acute respiratory syndrome coronavirus.
Kariwa H, Noda H, Nakauchi M, Ishizuka M, Hashiguchi K, Hashimoto S, Yoshii K, Asano A, Agui T, Kogaki H, Kurano Y, Uchida Y, Fujii N, Okada M, Takashima I. Kariwa H, et al. Jpn J Vet Res. 2008 Feb;55(4):115-27. Jpn J Vet Res. 2008. PMID: 18380153 - Human monoclonal antibodies to the S glycoprotein and related proteins as potential therapeutics for SARS.
Zhang MY, Choudhry V, Xiao X, Dimitrov DS. Zhang MY, et al. Curr Opin Mol Ther. 2005 Apr;7(2):151-6. Curr Opin Mol Ther. 2005. PMID: 15844623 Review.
Cited by
- SARS-CoV-2-specific CD4+ T cell longevity correlates with Th17-like phenotype.
Terahara K, Sato T, Adachi Y, Tonouchi K, Onodera T, Moriyama S, Sun L, Takano T, Nishiyama A, Kawana-Tachikawa A, Matano T, Matsumura T, Shinkai M, Isogawa M, Takahashi Y. Terahara K, et al. iScience. 2022 Sep 16;25(9):104959. doi: 10.1016/j.isci.2022.104959. Epub 2022 Aug 17. iScience. 2022. PMID: 35992306 Free PMC article. - Temperature-Responsive Liposome-Linked Immunosorbent Assay for the Rapid Detection of SARS-CoV-2 Using Immunoliposomes.
Hu R, Hotta M, Maruyama T, Fujisawa M, Sou K, Takeoka S. Hu R, et al. ACS Omega. 2022 Jul 21;7(30):26936-26944. doi: 10.1021/acsomega.2c03597. eCollection 2022 Aug 2. ACS Omega. 2022. PMID: 35915635 Free PMC article. - Bioinformatic prediction of immunodominant regions in spike protein for early diagnosis of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Zhuang S, Tang L, Dai Y, Feng X, Fang Y, Tang H, Jiang P, Wu X, Fang H, Chen H. Zhuang S, et al. PeerJ. 2021 Apr 8;9:e11232. doi: 10.7717/peerj.11232. eCollection 2021. PeerJ. 2021. PMID: 33889450 Free PMC article. - MRC5 cells engineered to express ACE2 serve as a model system for the discovery of antivirals targeting SARS-CoV-2.
Uemura K, Sasaki M, Sanaki T, Toba S, Takahashi Y, Orba Y, Hall WW, Maenaka K, Sawa H, Sato A. Uemura K, et al. Sci Rep. 2021 Mar 8;11(1):5376. doi: 10.1038/s41598-021-84882-7. Sci Rep. 2021. PMID: 33686154 Free PMC article. - Evaluation of clinical utility of novel coronavirus antigen detection reagent, Espline® SARS-CoV-2.
Aoki K, Nagasawa T, Ishii Y, Yagi S, Kashiwagi K, Miyazaki T, Tateda K. Aoki K, et al. J Infect Chemother. 2021 Feb;27(2):319-322. doi: 10.1016/j.jiac.2020.11.015. Epub 2020 Dec 23. J Infect Chemother. 2021. PMID: 33388232 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Miscellaneous